Severity Assessment and the Immediate and Long-Term Prognosis in Community-Acquired Pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 37, Issue 6, 2016, Pages 886-896

  Kolditz, Martin ^a   Braeken, Dionne ^b   Ewig, Santiago ^c   Rohde, Gernot ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Augusta Kranken Anstalt   (Germany)

Author keywords

community acquired pneumonia; CURB 65; mortality; pneumonia severity index; risk stratification

Indexed keywords

BIOLOGICAL MARKER; HYPERTENSIVE FACTOR; LACTIC ACID;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BREATHING RATE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFUSION; CONTROLLED STUDY; DISEASE SEVERITY ASSESSMENT; FEMALE; FUNCTIONAL STATUS; HIGH RISK PATIENT; HUMAN; INTERVENTION STUDY; LONG TERM CARE; LOW RISK PATIENT; MALE; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MORTALITY RISK; OXYGENATION; PATIENT IDENTIFICATION; PNEUMONIA SEVERITY INDEX; PREDICTOR VARIABLE; PRIORITY JOURNAL; BLOOD; COMMUNITY ACQUIRED INFECTION; EMERGENCY; MORTALITY; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

COMMUNITY-ACQUIRED INFECTIONS; EMERGENCIES; FEMALE; HUMANS; LACTIC ACID; MALE; PNEUMONIA; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 85006054028     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0036-1592127     Document Type: Article

References (111)

1. Welte T Torres A Nathwani D Clinical and economic burden of community-acquired pneumonia among adults in Europe Thorax 2012 67 1 71 79
2. Bauer T T Ewig S Marre R Suttorp N Welte T; CAPNETZ Study Group. CRB-65 predicts death from community-acquired pneumonia J Intern Med 2006 260 1 93 101
3. Carratalà J Fernández-Sabé N Ortega L, et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients Ann Intern Med 2005 142 3 165 172
4. Renaud B Coma E Labarere J, et al; Pneumocom Study Investigators. Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study Clin Infect Dis 2007 44 1 41 49
5. Akram A R Chalmers J D Hill A T Predicting mortality with severity assessment tools in out-patients with community-acquired pneumonia QJM 2011 104 10 871 879
6. McNally M Curtain J O'Brien K K Dimitrov B D Fahey T Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: systematic review and meta-analysis Br J Gen Pract 2010 60 579 e423 e433
7. Ewig S Birkner N Strauss R, et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality Thorax 2009 64 12 1062 1069
8. Aliberti S Brambilla A M Chalmers J D, et al. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis Respir Res 2014 15 27
9. Kolditz M Ewig S Klapdor B, et al; CAPNETZ study group. Community-acquired pneumonia as medical emergency: predictors of early deterioration Thorax 2015 70 6 551 558
10. Kolditz M Bauer T T König T Rohde G Ewig S 3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors Eur Respir J 2016 47 5 1572 1574
11. Mandell L A Wunderink R G Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 2007 44 02 S27 S72
12. Woodhead M Blasi F Ewig S, et al; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections - full version Clin Microbiol Infect 2011 17 06 E1 E59
13. Ewig S Höffken G Kern W V, et al. Management of adult community-acquired pneumonia and prevention-update 2016 [in German] Pneumologie 2016 70 3 151 200
14. Fine M J Auble T E Yealy D M, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 1997 336 4 243 250
15. Lim W S van der Eerden M M Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 2003 58 5 377 382
16. Chalmers J D Singanayagam A Akram A R, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis Thorax 2010 65 10 878 883
17. Loke Y K Kwok C S Niruban A Myint P K Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis Thorax 2010 65 10 884 890
18. Choudhury G Chalmers J D Mandal P, et al. Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients Eur Respir J 2011 38 3 643 648
19. Majumdar S R Eurich D T Gamble J M Senthilselvan A Marrie T J Oxygen saturations less than 92% are associated with major adverse events in outpatients with pneumonia: a population-based cohort study Clin Infect Dis 2011 52 3 325 331
20. Halm E A Atlas S J Borowsky L H, et al. Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors Arch Intern Med 2000 160 1 98 104
21. Marrie T J Lau C Y Wheeler S L Wong C J Vandervoort M K Feagan B G A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin JAMA 2000 283 6 749 755
22. Ewig S Welte T CRB-65 for the assessment of pneumonia severity: who could ask for more? Thorax 2008 63 8 665 666
23. Ewig S Bauer T Richter K, et al. Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups Eur Respir J 2013 41 4 917 922
24. Kolditz M Ewig S Schütte H Suttorp N Welte T Rohde G; CAPNETZ study group. Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score J Intern Med 2015 278 2 193 202
25. Dwyer R Hedlund J Darenberg J, et al. Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia Scand J Infect Dis 2011 43 6-7 448 455
26. Dwyer R Hedlund J Henriques-Normark B Kalin M Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia BMJ Open Respir Res 2014 1 1 e000038
27. Corrales-Medina V F Musher D M Wells G A Chirinos J A Chen L Fine M J Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality Circulation 2012 125 6 773 781
28. Aliberti S Ramirez J Cosentini R, et al. Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia ERJ Open Res 2015 1 00020 02015
29. El-Solh A A Alhajhusain A Abou Jaoude P Drinka P Validity of severity scores in hospitalized patients with nursing home-acquired pneumonia Chest 2010 138 6 1371 1376
30. Bauer T T Welte T Strauss R Bischoff H Richter K Ewig S Why do nonsurvivors from community-acquired pneumonia not receive ventilatory support? Lung 2013 191 4 417 424
31. Zeymer U Hambrecht R Theres H, et al. Treatment of ST-segment elevation acute myocardial infarction in hospitals with and without cardiac catheterization laboratory [in German] Dtsch Med Wochenschr 2013 138 39 1935 1940
32. Ewig S Torres A Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality Eur Respir J 2011 38 2 253 260
33. Ewig S Woodhead M Torres A Towards a sensible comprehension of severe community-acquired pneumonia Intensive Care Med 2011 37 2 214 223
34. Chalmers J D Taylor J K Mandal P, et al. Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care Clin Infect Dis 2011 53 6 503 511
35. Salih W Schembri S Chalmers J D Simplification of the IDSA/ATS criteria for severe CAP using meta-analysis and observational data Eur Respir J 2014 43 3 842 851
36. Dremsizov T Clermont G Kellum J A Kalassian K G Fine M J Angus D C Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest 2006 129 4 968 978
37. Phua J Ngerng W J Lim T K The impact of a delay in intensive care unit admission for community-acquired pneumonia Eur Respir J 2010 36 4 826 833
38. Renaud B Santin A Coma E, et al. Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia Crit Care Med 2009 37 11 2867 2874
39. Restrepo M I Mortensen E M Rello J Brody J Anzueto A Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality Chest 2010 137 3 552 557
40. Delgado M K Liu V Pines J M Kipnis P Gardner M N Escobar G J Risk factors for unplanned transfer to intensive care within 24 hours of admission from the emergency department in an integrated healthcare system J Hosp Med 2013 8 1 13 19
41. Lim H F Phua J Mukhopadhyay A, et al. IDSA/ATS minor criteria aid pre-intensive care unit resuscitation in severe community-acquired pneumonia Eur Respir J 2014 43 3 852 862
42. Ferrer R Martin-Loeches I Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program Crit Care Med 2014 42 8 1749 1755
43. Chamberlain D J Willis E M Bersten A B The severe sepsis bundles as processes of care: a meta-analysis Aust Crit Care 2011 24 4 229 243
44. Gattarello S Borgatta B Solé-Violán J, et al; Community-Acquired Pneumonia en la Unidad de Cuidados Intensivos II Study Investigators. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000-2013) Chest 2014 146 1 22 31
45. Hortmann M Heppner H J Popp S Lad T Christ M Reduction of mortality in community-acquired pneumonia after implementing standardized care bundles in the emergency department Eur J Emerg Med 2014 21 6 429 435
46. Guo Q Li H Y Li Y M, et al. Compliance with severe sepsis bundles and its effect on patient outcomes of severe community-acquired pneumonia in a limited resources country Arch Med Sci 2014 10 5 970 978
47. Kolditz M Ewig S Höffken G Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Eur Respir J 2013 41 4 974 984
48. Ewig S Ruiz M Mensa J, et al. Severe community-acquired pneumonia. Assessment of severity criteria Am J Respir Crit Care Med 1998 158 4 1102 1108
49. Charles P G Wolfe R Whitby M, et al; Australian Community-Acquired Pneumonia Study Collaboration. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia Clin Infect Dis 2008 47 3 375 384
50. España P P Capelastegui A Gorordo I, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia Am J Respir Crit Care Med 2006 174 11 1249 1256
51. Yandiola P P Capelastegui A Quintana J, et al. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia Chest 2009 135 6 1572 1579
52. Buising K L Thursky K A Black J F, et al. Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool Emerg Med Australas 2007 19 5 418 426
53. Renaud B Labarère J Coma E, et al. Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule Crit Care 2009 13 2 R54
54. Labarère J Schuetz P Renaud B Claessens Y E Albrich W Mueller B Validation of a clinical prediction model for early admission to the intensive care unit of patients with pneumonia Acad Emerg Med 2012 19 9 993 1003
55. Chalmers J D Mandal P Singanayagam A, et al. Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis Intensive Care Med 2011 37 9 1409 1420
56. Marti C Garin N Grosgurin O, et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis Crit Care 2012 16 4 R141
57. Suetrong B Walley K R Lactic acidosis in sepsis: it's not all anaerobic: implications for diagnosis and management Chest 2016 149 1 252 261
58. Tang Y Choi J Kim D, et al. Clinical predictors of adverse outcome in severe sepsis patients with lactate 2-4-mM admitted to the hospital QJM 2015 108 4 279 287
59. Casserly B Phillips G S Schorr C, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database Crit Care Med 2015 43 3 567 573
60. Shankar-Hari M Phillips G S Levy M L, et al; Sepsis Definitions Task Force. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA 2016 315 8 775 787
61. Jansen T C van Bommel J Schoonderbeek F J, et al; LACTATE study group. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial Am J Respir Crit Care Med 2010 182 6 752 761
62. Dettmer M Holthaus C V Fuller B M The impact of serial lactate monitoring on emergency department resuscitation interventions and clinical outcomes in severe sepsis and septic shock: an observational cohort study Shock 2015 43 1 55 61
63. Singer M Deutschman C S Seymour C W, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA 2016 315 8 801 810
64. Gwak M H Jo S Jeong T, et al. Initial serum lactate level is associated with inpatient mortality in patients with community-acquired pneumonia Am J Emerg Med 2015 33 5 685 690
65. Liu B Yin Q Chen Y X Zhao Y Z Li C S Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department Respir Med 2014 108 8 1204 1213
66. Chen Y X Li C S Lactate on emergency department arrival as a predictor of mortality and site-of-care in pneumonia patients: a cohort study Thorax 2015 70 5 404 410
67. Jo S Jeong T Lee J B Jin Y Yoon J Park B Validation of modified early warning score using serum lactate level in community-acquired pneumonia patients. The National Early Warning Score-Lactate score Am J Emerg Med 2016 34 3 536 541
68. Halm E A Fine M J Marrie T J, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines JAMA 1998 279 18 1452 1457
69. Carratalà J Garcia-Vidal C Ortega L, et al. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial Arch Intern Med 2012 172 12 922 928
70. Lepper P M Ott S Nüesch E, et al; German Community Acquired Pneumonia Competence Network. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study BMJ 2012 344 e3397
71. Chalmers J D Singanayagam A Hill A T C-reactive protein is an independent predictor of severity in community-acquired pneumonia Am J Med 2008 121 3 219 225
72. Krüger S Ewig S Marre R, et al; CAPNETZ Study Group. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes Eur Respir J 2008 31 2 349 355
73. Ramírez P Ferrer M Martí V, et al. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia Crit Care Med 2011 39 10 2211 2217
74. Schuetz P Suter-Widmer I Chaudri A Christ-Crain M Zimmerli W Mueller B; Procalcitonin-Guided Antibiotic Therapy and Hospitalisation in Patients with Lower Respiratory Tract Infections (ProHOSP) Study Group. Prognostic value of procalcitonin in community-acquired pneumonia Eur Respir J 2011 37 2 384 392
75. Charles P E Tinel C Barbar S, et al. Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome Crit Care 2009 13 2 R38
76. Shehabi Y Sterba M Garrett P M, et al; ProGUARD Study Investigators; ANZICS Clinical Trials Group. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial Am J Respir Crit Care Med 2014 190 10 1102 1110
77. Bruns A H Oosterheert J J Hak E Hoepelman A I Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia Eur Respir J 2008 32 3 726 732
78. Coelho L Póvoa P Almeida E, et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course Crit Care 2007 11 4 R92 R100
79. Oliveira C F Botoni F A Oliveira C R, et al. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial Crit Care Med 2013 41 10 2336 2343
80. Schuetz P Briel M Mueller B Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections JAMA 2013 309 7 717 718
81. de Jong E van Oers J A Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial Lancet Infect Dis 2016 16 7 819 827
82. Nowak A Breidthardt T Christ-Crain M, et al. Direct comparison of three natriuretic peptides for prediction of short-and long-term mortality in patients with community-acquired pneumonia Chest 2012 141 4 974 982
83. Krüger S Ewig S Giersdorf S Hartmann O Suttorp N Welte T; German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group. Cardiovascular and inflammatory biomarkers to predict short-and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ Am J Respir Crit Care Med 2010 182 11 1426 1434
84. Schuetz P Wolbers M Christ-Crain M, et al; ProHOSP Study Group. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections Crit Care 2010 14 3 R106
85. Kolditz M Halank M Schulte-Hubbert B Bergmann S Albrecht S Höffken G Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia Respir Med 2012 106 9 1320 1328
86. Renaud B Schuetz P Claessens Y E Labarère J Albrich W Mueller B Proadrenomedullin improves risk of early admission to ICU score for predicting early severe community-acquired pneumonia Chest 2012 142 6 1447 1454
87. España P P Capelastegui A Mar C, et al. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia J Infect 2015 70 5 457 466
88. Chalmers J D Singanayagam A Scally C Hill A T Admission D-dimer can identify low-risk patients with community-acquired pneumonia Ann Emerg Med 2009 53 5 633 638
89. Kolditz M Halank M Schulte-Hubbert B Höffken G Adrenal function is related to prognosis in moderate community-acquired pneumonia Eur Respir J 2010 36 3 615 621
90. Kolditz M Höffken G Martus P, et al; CAPNETZ study group. Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study BMC Infect Dis 2012 12 1 90
91. Viasus D Del Rio-Pertuz G Simonetti A F, et al. Biomarkers for predicting short-term mortality in community-acquired pneumonia: a systematic review and meta-analysis J Infect 2016 72 3 273 282
92. Albrich W C Rüegger K Dusemund F, et al. Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial Eur Respir J 2013 42 4 1064 1075
93. Torres A Sibila O Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial JAMA 2015 313 7 677 686
94. Frat J P Thille A W Mercat A, et al; FLORALI Study Group; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure N Engl J Med 2015 372 23 2185 2196
95. Sligl W I Asadi L Eurich D T Tjosvold L Marrie T J Majumdar S R Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis Crit Care Med 2014 42 2 420 432
96. Welte T Dellinger R P Ebelt H, et al. Concept for a study design in patients with severe community-acquired pneumonia: a randomised controlled trial with a novel IGM-enriched immunoglobulin preparation-The CIGMA study Respir Med 2015 109 6 758 767
97. Davenport E E Burnham K L Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study Lancet Respir Med 2016 4 4 259 271
98. Holter J C Ueland T Jenum P A, et al. Risk factors for long-term mortality after hospitalization for community-acquired pneumonia: a 5-year prospective follow-up study PLoS ONE 2016 11 2 e0148741
99. Eurich D T Marrie T J Minhas-Sandhu J K Majumdar S R Ten-year mortality after community-acquired pneumonia. A prospective cohort Am J Respir Crit Care Med 2015 192 5 597 604
100. Yende S D'Angelo G Kellum J A, et al; GenIMS Investigators. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis Am J Respir Crit Care Med 2008 177 11 1242 1247
101. Johnstone J Eurich D T Majumdar S R Jin Y Marrie T J Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study Medicine (Baltimore) 2008 87 6 329 334
102. Bruns A H Oosterheert J J Cucciolillo M C, et al. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population Clin Microbiol Infect 2011 17 5 763 768
103. Kaplan V Clermont G Griffin M F, et al. Pneumonia: still the old man's friend? Arch Intern Med 2003 163 3 317 323
104. Bordon J Wiemken T Peyrani P, et al; CAPO Study Group. Decrease in long-term survival for hospitalized patients with community-acquired pneumonia Chest 2010 138 2 279 283
105. Mortensen E M Kapoor W N Chang C C Fine M J Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia Clin Infect Dis 2003 37 12 1617 1624
106. Myles P R Hubbard R B Gibson J E Pogson Z Smith C J McKeever T M Pneumonia mortality in a UK general practice population cohort Eur J Public Health 2009 19 5 521 526
107. Restrepo M I Faverio P Anzueto A Long-term prognosis in community-acquired pneumonia Curr Opin Infect Dis 2013 26 2 151 158
108. Guertler C Wirz B Christ-Crain M Zimmerli W Mueller B Schuetz P Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Eur Respir J 2011 37 6 1439 1446
109. Alan M Grolimund E Kutz A, et al; ProHOSP study group. Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study J Intern Med 2015 278 2 174 184
110. Cecere L M Rubenfeld G D Park D R Root R K Goss C H Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia Respiration 2010 79 2 128 136
111. Waterer G W Kessler L A Wunderink R G Medium-term survival after hospitalization with community-acquired pneumonia Am J Respir Crit Care Med 2004 169 8 910 914